186 related articles for article (PubMed ID: 3735276)
1. Current practice in antimalarial drug prescribing in rheumatoid arthritis.
Bellamy N; Brooks PM
J Rheumatol; 1986 Jun; 13(3):551-5. PubMed ID: 3735276
[TBL] [Abstract][Full Text] [Related]
2. Prescribing trends in disease modifying antirheumatic drugs for rheumatoid arthritis: a survey of practicing Canadian rheumatologists.
Pope JE; Hong P; Koehler BE
J Rheumatol; 2002 Feb; 29(2):255-60. PubMed ID: 11838842
[TBL] [Abstract][Full Text] [Related]
3. Antimalarial treatment of rheumatoid arthritis: 1985 status.
Rynes RI
J Rheumatol; 1985 Aug; 12(4):657-9. PubMed ID: 4057186
[No Abstract] [Full Text] [Related]
4. Hydroxychloroquine and chloroquine: assessing the risk of retinal toxicity.
Aylward JM
J Am Optom Assoc; 1993 Nov; 64(11):787-97. PubMed ID: 8120333
[TBL] [Abstract][Full Text] [Related]
5. The role of anti-malarials in rheumatoid arthritis--the American experience.
Khraishi MM; Singh G
Lupus; 1996 Jun; 5 Suppl 1():S41-4. PubMed ID: 8803910
[TBL] [Abstract][Full Text] [Related]
6. The prescribing of chloroquine and hydroxychloroquine by consultant rheumatologists in the UK.
Kay EA; Rees JA; Jayson MI
Br J Rheumatol; 1987 Oct; 26(5):375-8. PubMed ID: 3664163
[TBL] [Abstract][Full Text] [Related]
7. Current practices for monitoring ocular toxicity related to hydroxychloroquine (Plaquenil) therapy.
Mazzuca SA; Yung R; Brandt KD; Yee RD; Katz BP
J Rheumatol; 1994 Jan; 21(1):59-63. PubMed ID: 8151589
[TBL] [Abstract][Full Text] [Related]
8. Antimalarial drug-induced aquagenic-type pruritus in patients with lupus.
Jiménez-Alonso J; Tercedor J; Jáimez L; García-Lora E
Arthritis Rheum; 1998 Apr; 41(4):744-5. PubMed ID: 9550488
[No Abstract] [Full Text] [Related]
9. Fatal antimalarial-induced cardiomyopathy: report of 2 cases.
Azimian M; Gultekin SH; Hata JL; Atkinson JB; Ely KA; Fuchs HA; Mobley BC
J Clin Rheumatol; 2012 Oct; 18(7):363-6. PubMed ID: 23047537
[TBL] [Abstract][Full Text] [Related]
10. A rheumatologist's verdict on the safety of chloroquine versus hydroxychloroquine. Liability in off-label prescribing.
Houpt JB
J Rheumatol; 1999 Sep; 26(9):1864-6. PubMed ID: 10493661
[No Abstract] [Full Text] [Related]
11. Are the Current Recommendations for Chloroquine and Hydroxychloroquine Screening Appropriate?
Schwartzman S; Samson CM
Rheum Dis Clin North Am; 2019 Aug; 45(3):359-367. PubMed ID: 31277749
[TBL] [Abstract][Full Text] [Related]
12. Antimalarial drugs in pregnancy--the North American experience.
Parke AL; Rothfield NF
Lupus; 1996 Jun; 5 Suppl 1():S67-9. PubMed ID: 8803915
[TBL] [Abstract][Full Text] [Related]
13. Antimalarial treatment of rheumatoid arthritis.
Zvaifler NJ
Med Clin North Am; 1968 May; 52(3):759-64. PubMed ID: 5653948
[No Abstract] [Full Text] [Related]
14. Antimalarial drug induced decrease in creatinine clearance.
Landewé RB; Vergouwen MS; Goeei The SG; Van Rijthoven AW; Breedveld FC; Dijkmans BA
J Rheumatol; 1995 Jan; 22(1):34-7. PubMed ID: 7699677
[TBL] [Abstract][Full Text] [Related]
15. Lupus erythematosus tumidus: response to antimalarial treatment in 36 patients with emphasis on smoking.
Kreuter A; Gaifullina R; Tigges C; Kirschke J; Altmeyer P; Gambichler T
Arch Dermatol; 2009 Mar; 145(3):244-8. PubMed ID: 19289751
[TBL] [Abstract][Full Text] [Related]
16. [Synthetic antimalarials in the therapy of rheumatoid arthritis: adverse effects and advantages].
Lanciani P
Minerva Med; 1985 Oct; 76(38):1743-4. PubMed ID: 2864664
[TBL] [Abstract][Full Text] [Related]
17. Antimalarial therapy in SLE.
Lanham JG; Hughes GR
Clin Rheum Dis; 1982 Apr; 8(1):279-98. PubMed ID: 6749400
[No Abstract] [Full Text] [Related]
18. Third-degree atrioventricular block in a patient under chloroquine therapy.
Guedira N; Hajjaj-Hassouni N; Srairi JE; el Hassani S; Fellat R; Benomar M
Rev Rhum Engl Ed; 1998 Jan; 65(1):58-62. PubMed ID: 9523387
[TBL] [Abstract][Full Text] [Related]
19. [Antimalarial's retinopaty remains a current threat].
Chiffoleau A; Guillet A; Zanlonghi X; Jolliet P
Presse Med; 2009 Apr; 38(4):662-3. PubMed ID: 19135848
[No Abstract] [Full Text] [Related]
20. [Eye toxicity of antimalarial agents].
Graña Gil J; Cabana Vázquez M; Vázquez González A; Sánchez Meizoso MO
An Med Interna; 2002 Apr; 19(4):189-91. PubMed ID: 12090061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
